Flotufolastat f-18 gallium - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for flotufolastat f-18 gallium and what is the scope of freedom to operate?

Flotufolastat f-18 gallium is the generic ingredient in one branded drug marketed by Blue Earth and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Flotufolastat f-18 gallium has thirty patent family members in fourteen countries.

One supplier is listed for this compound.

Summary for flotufolastat f-18 gallium

International Patents:	30
US Patents:	2
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
DailyMed Link:	flotufolastat f-18 gallium at DailyMed

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for flotufolastat f-18 gallium

Generic Entry Date for flotufolastat f-18 gallium^: ⤷ Sign Up* Constraining patent/regulatory exclusivity: NEW CHEMICAL ENTITY Dosage: SOLUTION;INTRAVENOUS

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for flotufolastat f-18 gallium

Drug Class	Radioactive Diagnostic Agent
Mechanism of Action	Positron Emitting Activity

US Patents and Regulatory Information for flotufolastat f-18 gallium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Blue Earth	POSLUMA	flotufolastat f-18 gallium	SOLUTION;INTRAVENOUS	216023-001	May 25, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y		⤷ Sign Up
Blue Earth	POSLUMA	flotufolastat f-18 gallium	SOLUTION;INTRAVENOUS	216023-001	May 25, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Blue Earth	POSLUMA	flotufolastat f-18 gallium	SOLUTION;INTRAVENOUS	216023-001	May 25, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for flotufolastat f-18 gallium

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	2022101601	デュアルモードの放射性トレーサーおよび療法剤	⤷ Sign Up
Eurasian Patent Organization	202090370	ДВУХРЕЖИМНАЯ РАДИОАКТИВНАЯ МЕТКА И РАДИОТЕРАПЕВТИЧЕСКОЕ СРЕДСТВО	⤷ Sign Up
Brazil	112022020359	FORMULAÇÕES FARMACÊUTICAS	⤷ Sign Up
Mexico	2020000352	MARCADOR RADIOACTIVO DE MODO DUAL Y TERAPEUTICOS. (DUAL MODE RADIOTRACER AND -THERAPEUTICS.)	⤷ Sign Up
Australia	2024200440	Dual mode radiotracer and -therapeutics	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Summary for flotufolastat f-18 gallium

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for flotufolastat f-18 gallium

Pharmacology for flotufolastat f-18 gallium

Make Better Decisions: Try a trial or see plans & pricing

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for flotufolastat f-18 gallium